Best Practice & Research Clinical Obstetrics & Gynaecology
Volume 24, Issue 2 , Pages 157-171 , April 2010

Menstrual disturbances in puberty

  • Efthimios Deligeoroglou, MD, PhD (Assoc. Professor of Ob/Gyn, Secretary General FIGIJ (International Federation of Pediatric - Adolescent Gynecology), Vice-President EURAPAG (European Association of Pediatric - Adolescent Gynecology))

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +30 210 7798111, +30 210 7217835; Fax: +30 210 7286282.
    • ,
  • Pandelis Tsimaris, MD (Ob/Gyn, IFEPAG Fellow (International Fellowship on Paediatric - Adolescent Gynecology))

References 

  1. Diaz A, Laufer MR, Breech LL American Academy of Pediatrics Committee on Adolescence American College of Obstetricians and Gynecologists Committee on Adolescent Health Care. Menstruation in girls and adolescents: using the menstrual cycle as a vital sign. Pediatrics. 2006;118:2245–2250
  2. Ibáñez L, Potau N, Zampolli M, et al. Hyperinsulinemia and decreased insulin-like growth factor-binding protein-1 are common features in prepubertal and pubertal girls with a history of premature pubarche. J Clin Endocrinol Metab. 1997;82:2283–2288
  3. Hickey M, Balen A. Menstrual disorders in adolescence: investigation and management. Hum Reprod Update. 2003;9:493–504
  4. Mann DR, Plant TM. Leptin and pubertal development. Semin Reprod Med. 2002;20:93–102
  5. Clément K, Vaisse C, Lahlou N, et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature. 1998;392:398–401
  6. Deligeoroglou E, Tsimaris P, Deliveliotou A, et al. Menstrual disorders during adolescence. Pediatr Endocrinol Rev. 2006;3(Suppl. 1):150–159
  7. World Health Organization Task Force on Adolescent Reproductive Health . World Health Organization multicenter study on menstrual and ovulatory patterns in adolescent girls. II. Longitudinal study of menstrual patterns in the early postmenarcheal period, duration of bleeding episodes and menstrual cycles. J Adolesc Health Care. 1986;7:236–244
  8. Treloar AE, Boynton RE, Behn BG, et al. Variation of the human menstrual cycle through reproductive life. Int J Fertil. 1967;12:77–126
  9. Vollman RF. The menstrual cycle. Major Probl Obstet Gynecol. 1977;7:1–193
  10. Herman-Giddens ME, Slora EJ, Wasserman RC, et al. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the pediatric research in office settings network. Pediatrics. 1997;99:505–512
  11. Root AW. Precocious puberty. Pediatr Rev. 2000;21:10–19
  12. Ibáñez L, Potau N, Dunger D, et al. Precocious pubarche in girls and the development of androgen excess. J Pediatr Endocrinol Metab. 2000;13(Suppl. 5):1261–1263
  13. Pathomvanich A, Merke DP, Chrousos GP. Early puberty: a cautionary tale. Pediatrics. 2000;105:115–116
  14. Léger J, Reynaud R, Czernichow P. Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment?. J Pediatr. 2000;137:819–825
  15. The Practice Committee of the American Society for Reproductive Medicine . Current evaluation of amenorrhea. Fertil Steril. 2008;90(Suppl. 3):S219–S225
  16. Slap GB. Menstrual disorders in adolescence. Best Pract Res Clin Obstet Gynaecol. 2003;17:75–92
  17. Frisch RE, McArthur JW. Menstrual cycles: fatness as a determinant of minimum weight for height necessary for their maintenance or onset. Science. 1974;185:949–951
  18. Warren MP, Goodman LR. Exercise-induced endocrine pathologies. J Endocrinol Invest. 2003;26:873–888
  19. Meczekalski B, Podfigurna-Stopa A, Warenik-Szymankiewicz A, et al. Functional hypothalamic amenorrhea: current view on neuroendocrine aberrations. Gynecol Endocrinol. 2008;24:4–11
  20. Vescovi JD, Jamal SA, De Souza MJ. Strategies to reverse bone loss in women with functional hypothalamic amenorrhea: a systematic review of the literature. Osteoporos Int. 2008;19:465–478
  21. Jayasinghe Y, Grover SR, Zacharin M. Current concepts in bone and reproductive health in adolescents with anorexia nervosa. BJOG. 2008;115:304–315
  22. Wallaschofski H, Kobsar A, Sokolova O, et al. Co-activation of platelets by prolactin or leptin–pathophysiological findings and clinical implications. Horm Metab Res. 2004;36:1–6
  23. Patel SS, Bamigboye V. Hyperprolactinaemia. J Obstet Gynaecol. 2007;27:455–459
  24. Vallette-Kasic S, Morange-Ramos I, Selim A, et al. Macroprolactinemia revisited: a study on 106 patients. J Clin Endocrinol Metab. 2002;87:581–588
  25. Miller KK. Management of hyperprolactinemia in patients receiving antipsychotics. CNS Spectr. 2004;9(Suppl. 7):28–32
  26. Nippita TA, Baber RJ. Premature ovarian failure: a review. Climacteric. 2007;10(1):11–22
  27. Allingham-Hawkins DJ, Babul-Hirji R, Chitayat D, et al. Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study–preliminary data. Am J Med Genet. 1999;83:322–325
  28. Nelson LM. Primary ovarian insufficiency. N Engl J Med. 2009;360:606–614
  29. Kalantaridou SN, Nelson LM. Premature ovarian failure is not premature menopause. Ann N Y Acad Sci. 2000;900:393–402
  30. Demeestere I, Simon P, Englert Y, et al. Preliminary experience of ovarian tissue cryopreservation procedure: alternatives, perspectives and feasibility. Reprod Biomed Online. 2003;7:572–579
  31. Fraser IS, Sungurtekin U. Defining menstrual disturbances. In:  Maclean A,  O'Brien PMS editor. Study group on menstrual disorders. Royal College of Obstetricians and Gynecologist; 2000;p. 141–152
  32. Minjarez DA, Bradshaw KD. Abnormal uterine bleeding in adolescents. Obstet Gynecol Clin North Am. 2000;27:63–78
  33. Claessens EA, Cowell CA. Dysfunctional uterine bleeding in the adolescent. Pediatr Clin North Am. 1981;28:369–378
  34. Kouides PA. Obstetric and gynaecological aspects of von Willebrand disease. Best Pract Res Clin Haematol. 2000;14:381–399
  35. Bevan JA, Maloney KW, Hillery CA, et al. Bleeding disorders: A common cause of menorrhagia in adolescents. J Pediatr. 2001;138:856–861
  36. Kadir RA, Aledort LM. Obstetrical and gynaecological bleeding: a common presenting symptom. Clin Lab Haematol. 2000;22(Suppl. 1):12–16
  37. Mammen EF. Haemostatic dysfunction related to liver diseases and liver transplantation. In:  Beutler E,  Lichtman MA,  Coller BS, et al. editor. Williams hematology. 6th ed.. New York: McGraw-Hill Professional; 2001;p. 1673–1676
  38. Deligeoroglou E. Dysfunctional uterine bleeding. Ann N Y Acad Sci. 1997;816:158–164
  39. Kriplani A, Kulshrestha V, Agarwal N, et al. Role of tranexamic acid in management of dysfunctional uterine bleeding in comparison with medroxyprogesterone acetate. J Obstet Gynaecol. 2006;26:673–678
  40. Andersch B, Milsom I. An epidemiologic study of young women with dysmenorrhea. Am J Obstet Gynecol. 1982;144:655–660
  41. Klein JR, Litt IF. Epidemiology of adolescent dysmenorrhea. Pediatrics. 1981;68:661–664
  42. Deligeoroglou E. Dysmenorrhea. Ann N Y Acad Sci. 2000;900:237–244
  43. Creatsas G, Deligeoroglou E, Zachari A, et al. Prostaglandins: PGF2 alpha, PGE2, 6-keto-PGF1 alpha and TXB2 serum levels in dysmenorrheic adolescents before, during and after treatment with oral contraceptives. Eur J Obstet Gynecol Reprod Biol. 1990;36:292–298

PII: S1521-6934(09)00139-4

doi: 10.1016/j.bpobgyn.2009.11.001

Best Practice & Research Clinical Obstetrics & Gynaecology
Volume 24, Issue 2 , Pages 157-171 , April 2010

Article Tools

* Image Usage & Resolution